Donald Trump’s treatment reminds us to hedge bets on Covid-19 research

• Leading US expert Anthony Fauci says he strongly suspects that Regn-Cov2, a treatment using cloned antibodies, was behind the US president’s recovery
• But high costs may limit the treatment’s accessibility, and uncertainties have been raised by pharma firm Eli Lilly’s suspension of its trial